Project Grant R35GM158265
Award Date
7/1/25
Completion Date
4/30/30
Dollars Obligated
$563K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program. The grant, effective August 1, 2024 through May 31, 2029, will support research to expand access to molecular complexity through the synthesis of natural products. Key focus areas include developing dearomative transformations of aromatic compounds and desymmetrization...
This federal Project Grant award of $337,949 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to comprehensively classify and predict the function of intrinsically disordered protein regions. The University of Texas Southwestern Medical Center, the prime grantee, will use computational methods to categorize the modular sequence organization of disordered protein regions across different organisms....
This $368,110 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to study the structures and properties of key enzymatic intermediates involved in oxygenase chemistry. The research aims to develop peptide-based synthetic models that can mimic the active sites and reactivity of non-heme iron and copper oxygenases, which are critical for metabolism, natural product...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), is funding research at the University of Wisconsin - Madison to engineer promiscuous enzymes for the synthesis of biological building blocks. The $800,308 award supports mechanistic analysis of certain pyridoxal-phosphate dependent enzymes that can catalyze stand-alone C-C bond forming reactions, as well as the development of new...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of engineered enzymes that can be activated to perform targeted modifications of cellular proteins. The $1,602,000 award to the Dana-Farber Cancer Institute, Inc. (DFCI) will fund research to design and apply novel autoinhibited enzymes that can toggle between inactive and active conformations in response...
The National Institute of General Medical Sciences (NIGMS) awarded a $699,830 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to The University of Texas Southwestern Medical Center (UT Southwestern) in Dallas, TX. The goal of this 5-year award, effective September 1, 2024, is to determine the biochemical and molecular mechanisms of RNASE Z-mediated deampylation, a newly discovered regulatory process involving the covalent addition and removal of...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,590,000 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to the Massachusetts Institute of Technology (MIT) to advance research on computational modeling and machine learning for enzymatic and biomimetic C-H activation. Over the 5-year project period from August 2024 to May 2029, the PI will: 1) develop models for predicting regioselectivity in non-heme iron enzymes, 2) systematically...
This federal Project Grant award of $419,375 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research to define the functional dynamics of multi-domain redox enzymes, such as nitric oxide synthase (NOS), which are crucial for diverse signaling processes and disease states. The research aims to provide unprecedented understanding of how regulatory interactions and modifications...
The National Institute of General Medical Sciences (NIGMS) awarded a $528,129 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Connecticut Health Center (UCHC) to conduct research on the ubiquitin-proteasome pathway and its role in human disease. The overarching goal is to develop a detailed understanding of how components of this critical protein degradation system recognize substrates and execute their function, which is crucial for...